13.10.2022 | Original Article
Delayed Diagnosis of Chronic Necrotizing Granulomatous Skin Lesions due to TAP2 Deficiency
verfasst von:
Ilad Alavi Darazam, Atousa Hakamifard, Mana Momenilandi, Marie Materna, Farid Javandoust Gharehbagh, Mohammad Shahrooei, Nasrin Alipour Olyaei, Farahnaz Bidari Zerehpoosh, Antoine Fayand, Firouze Hatami, Legha Lotfollahi, Nahal Mansouri, Jean-Laurent Casanova, Vivien Béziat, Davood Mansouri
Erschienen in:
Journal of Clinical Immunology
|
Ausgabe 1/2023
Einloggen, um Zugang zu erhalten
Abstract
Major histocompatibility complex class I (MHC-I) deficiency, also known as bare lymphocyte syndrome type 1 (BLS-1), is a rare autosomal recessively inherited immunodeficiency disorder with remarkable clinical and biological heterogeneity. Transporter associated with antigen processing (TAP) is a member of the ATP-binding cassette superfamily of transporters and consists of two subunits, TAP1 or TAP2. Any defect resulting from a mutation or deletion of these two subunits may adversely affect the peptide translocation in the endoplasmic reticulum, which is an important process for properly assembling MHC-I molecules. To date, only 12 TAP2-deficient patients were reported in the literature. Herein, we described two Iranian cases with 2 and 3 decades of delayed diagnosis of chronic necrotizing granulomatous skin lesions due to TAP2 deficiency without pulmonary involvement. Segregation analysis in family members identified 3 additional homozygous asymptomatic carriers. In both asymptomatic and symptomatic carriers, HLA-I expression was only 4–15% of the one observed in healthy controls. We performed the first deep immunophenotyping in TAP2-deficient patients. While total CD8 T cell counts were normal as previously reported, the patients showed strongly impaired naïve CD8 T cell counts. Mucosal-associated invariant T (MAIT) cells and invariant natural killer T (iNKT) cell counts were increased.